Objective: To assess inter-and intrascanner variability in volumetry of solid pulmonary nodules in an anthropomorphic thoracic phantom using low-dose CT. Methods: Five spherical solid artificial nodules [diameters 3, 5, 8, 10 and 12 mm; CT density 1100 Hounsfield units (HU)] were randomly placed inside an anthropomorphic thoracic phantom in different combinations. The phantom was examined on two 64-row multidetector CT (64-MDCT) systems (CT-A and CT-B) from different vendors with a low-dose protocol. Each CT examination was performed three times. The CT examinations were evaluated twice by independent blinded observers. Nodule volume was semi-automatically measured by dedicated software. Interscanner variability was evaluated by Bland-Altman analysis and expressed as 95% confidence interval (CI) of relative differences. Intrascanner variability was expressed as 95% CI of relative variation from the mean.Results: No significant difference in CT-derived volume was found between CT-A and CT-B, except for the 3-mm nodules (p,0.05). The 95% CI of interscanner variability was within 641.6%, 618.2% and 64.9% for 3, 5 and $8 mm nodules, respectively. The 95% CI of intrascanner variability was within 628.6%, 613.4% and 62.6% for 3, 5 and $8 mm nodules, respectively. Conclusion: Different 64-MDCT scanners in low-dose settings yield good agreement in volumetry of artificial pulmonary nodules between 5 mm and 12 mm in diameter. Inter-and intrascanner variability decreases at a larger nodule size to a maximum of 4.9% for $8 mm nodules.
Advances in knowledge:The commonly accepted cut-off of 25% to determine nodule growth has the potential to be reduced for $8 mm nodules. This offers the possibility of reducing the interval for repeated CT scans in lung cancer screenings.Lung cancer is the primary cancer in males and the second most common cancer in females worldwide, causing 18% of the total number of deaths [1]. Many lung cancers are found at a relatively late stage, resulting in a 5-year survival of only 15% or less [2]. Low-dose CT is a promising screening method for early detection of lung cancer [3][4][5][6][7]. The first result indicates that CT lung cancer screening can reduce lung cancer-specific mortality [8].